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Abstract
CD36 is a ubiquitous membrane glycoprotein that binds long-chain fatty acids. The presence of a functional CD36 is
required for the induction of satiety by a lipid load and its role as a lipid receptor driving cellular signal has recently been
demonstrated. Our project aimed to further explore the role of intestinal CD36 in the regulation of food intake. Duodenal
infusions of vehicle or sulfo-N-succinimidyl-oleate (SSO) was performed prior to acute infusions of saline or Intralipid (IL) in
mice. Infusion of minute quantities of IL induced a decrease in food intake (FI) compared to saline. Infusion of SSO had the
same effect but no additive inhibitory effect was observed in presence of IL. No IL- or SSO-mediated satiety occurred in
CD36-null mice. To determine whether the CD36-mediated hypophagic effect of lipids was maintained in animals fed a
satietogen diet, mice were subjected to a High-Protein diet (HPD). Concomitantly with the satiety effect, a rise in intestinal
CD36 gene expression was observed. No satiety effect occurred in CD36-null mice. HPD-fed WT mice showed a diminished
FI compared to control mice, after saline duodenal infusion. But there was no further decrease after lipid infusion. The lipid-
induced decrease in FI observed on control mice was accompanied by a rise in jejunal oleylethanolamide (OEA). Its level was
higher in HPD-fed mice than in controls after saline infusion and was not changed by lipids. Overall, we demonstrate that
lipid binding to intestinal CD36 is sufficient to produce a satiety effect. Moreover, it could participate in the satiety effect
induced by HPD. Intestine can modulate FI by several mechanisms including an increase in OEA production and CD36 gene
expression. Furthermore, intestine of mice adapted to HPD have a diminished capacity to modulate their food intake in
response to dietary lipids.
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Introduction
CD36 is a multifunctional plasma membrane glycoprotein
expressed by a broad variety of tissues [1,2]. This receptor-like
protein is able to bind multiple compounds such as oxidized LDL
[3], collagen [4] or thrombospondin [5]. It also displays a very high
affinity (i.e. in nanomolar range) for long-chain fatty acids (LCFA).
Despiteitsmultifunctionality,CD36generallyplaysaspecificrolein
a given cell type. For example, it is involved in collagen-mediated
cytoadhesion in platelets, whereas it mediates LCFA uptake in
myocytes. Thiscell specificity of function probably results from both
cellular context (genotype and microenvironment) and aspects of
CD36 itself. Indeed, regulation of the gene encoding this receptor is
unusually complex [6] and this protein is subject to several post-
translational modifications in a tissue-specific manner [7]. Recently,
CD36 has been identified in rodent gustatory papillae as a lipid
sensor involved in both the preference for fatty foods and cephalic
phase of the digestion [8,9]. CD36 is also found in the small
intestine, in which its mRNA and protein levels are higher in the
proximal parts (duodenum and jejunum), the main sites of fat
absorption [10,11]. Moreover, its localization is strictly restricted to
the brush border membrane of differentiated enterocytes
[10,12,13]. Although this location raises the possibility of an
involvement in lipid uptake by intestinal cells, the specific role of
CD36 in the small intestine is not yet fully understood. If
comparison between wild-type and CD36-null mice has clearly
shown an implication of CD36 in the formation, secretion and
clearance of intestinal lipoproteins [14,15], its involvement in FA
uptake remains more elusive [16]. Indeed, some investigators report
that there is no alteration of global LCFA absorption in Cd36-
invalidated mice [13,16], while others suggest that CD36 plays a
role in LCFA uptake in the duodenum and proximal jejunum, but
not the distal intestine [17]. Alternatively, it has been demonstrated
that intestinal CD36 exerts also a role of lipid receptor, driving
cellular signals stimulating chylomicron synthesis [13].
It is known that a lipid infusion into the intestinal lumen leads to
a decrease in food intake [18] through mechanism which remains
to be clarified. It was recently shown that this phenomenon could
be in part related to the generation/mobilization of the lipid
messenger oleoylethanolamide (OEA) by the jejunum mucosa,
specifically in response to dietary lipids [19]. Using mice displaying
a total invalidation of the Cd36 gene, Schwartz et al have reported
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because CD36-null mice are insensitive to the feeding inhibitory
effects of duodenal lipid infusion [19]. They conclude that intestinal
CD36, by facilitating oleate uptake as a precursor of OEA and/or
its synthesis could raise the production of OEA. According to our
recent data [13], an involvement of CD36 as lipid receptor at the
origin of cell signalling, is an alternative hypothesis explaining its
effect on OEA quantity in jejuna mucosa [19].
To further explore the role of intestinal CD36 in the regulation
of feeding behaviour, impact of an acute duodenal infusion of
nutritional (lipids) and/or pharmacological (sulfo-N-succinimidyl
oleate, SSO) CD36 ligands on the regulation of food intake was
studied in wild-type and CD36-null mice. High-protein diets
(HPD) are known to induce a prolonged decrease in food intake
[20,21]. To assess the relative anorexic effect of dietary lipids, we
next explored whether the hypophagic effect of lipids was identical
in mice subjected to a standard (control) or a HP diet.
Materials and Methods
Animals
All procedures were performed with the approval of the
Regional Committee of Ethics for Animal Experiments.
Wild-type (Harlan, Le Marcoulet, France) and CD36 null male
C57Bl/6J [22] mice were housed in a ventilated cabinet at 21uC
with inverted light/dark cycle (darkness from 1:30 pm to 1:30 am)
and free access to water and standard chow (A04, SAFE, Augy,
France). For the intraduodenal infusion experiments, 5-week old
mice were fasted for 6 hours and anesthetized using isoflurane
throughout the surgical procedure. A silicone catheter (0.31 mm,
inner diameter) was placed in the duodenum through a small
incision and fastened using surgical adhesive (3M Vetbond tissue
adhesive, Centravet, Lapalisse, France). The catheter was
threaded under the skin to exit through an incision in the back
of the neck. Duodenal catheters were flushed every day with a
mixture of polyvinylpyrrolidone and marbocyl to avoid clogging of
the catheter, mixture supplemented every two days with
ketoprofen. Mice were allowed to recover for one week after
surgery. Catheterization allowed us to infuse solutions directly into
the duodenum of awake mice, after a 5-hour daytime fast.
Duodenal infusions
Experiment 1: Effect of a lipid infusion on short-term
food intake. After surgery, control mice were maintained on
standard chow and infused, in a first series of experiments, with
either isotonic saline solution or 20% Intralipid emulsion (IL from
Fresenius Kabi France, Se `vres. It contains 20% soybean oil, 1.2%
egg yolk phospholipids and 2.25% glycerine in water), at a rate of
6 mL/min during 10 min (0.12 Kcal infused). The end of the
infusion/refeeding corresponds to the beginning of the dark period
when mice were disconnected from the infusion pump. Food
intake (one pellet of standard chow was weighed immediately
before and after the test) was measured 30 min, 1 and 2 hours
after the end of the infusion (Fig 1). Each animal was tested for
each treatment condition alternatively, which means that each
animal was its own control. Following feeding tests, mice were
killed by cervical dislocation 45 min after the end of one type of
experimental perfusion and different parts of the small intestine as
well as total hypothalamus were recovered.
Experiment 2: Effect of sulfo-N-succinimidyl oleate on
food intake measured after saline or Intralipid
perfusion. In a second series of experiments, control and
CD36-null mice (kind gift of Dr. Maria Febbraio from Lerner
Research Institute, Cleveland, OH, USA) were infused prior to the
saline and IL infusions, with either 2-pyrrolidone, Pyrr (vehicle) or
sulfo-N-succinimidyl oleate, SSO (20 mM solution infused at a rate
of 3 mL/min during 5 min). To avoid the infusion of
dimethylsulfoxide, DMSO (the classical solvent of SSO), we used
2-pyrrolidone which has the advantage to make SSO soluble (F.
Falson, personal communication) and to be miscible in water. The
same mouse was alternatively exposed to the different infusions:
pre-infusion of either 2-pyrrolidone or SSO followed by either
saline or IL infusion (Fig 1). SSO specifically binds to CD36 and
arrests the LCFA transport into adipocytes [1]. It was used in these
experiments to specifically inhibit CD36 present in intestine cells.
Food intake was measured as above.
Experiment 3: High-protein diet and lipid sensing. Five-
week old male wild-type and CD36 null male C57Bl/6J mice were
maintained either on standard chow or on an isocaloric protein-
enriched diet, HPD (SAFE, 54% protein versus 16.1% in standard
chow) up to 30 days (Table 1). Weight and food intake were
recorded every day. Food intake was expressed as grams of food
consumed by gram of body weight to obviate any differences in
body weight between mice. Three groups of wild-type HPD mice
were separated and maintained on HP diet for 4, 12 and 30 days.
At the end of the experiments, mice were killed by cervical
dislocation after a 6h-fast. Blood and different parts of the small
intestine were recovered either as total tissue (RNA preparation) or
the mucosa was scraped off with a spatula (proteins), frozen
immediately in liquid nitrogen and stored at 280uC until used.
Figure 1. Experimental protocol and infusions.
doi:10.1371/journal.pone.0030686.g001
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above on control or 12 day-HPD fed mice of same age. NaCl and
IL perfusions were performed as above, each animal being its own
control. HPD mice were fed the same HPD food before and after
the infusion experiments. As above, mice were divided into
different experimental groups for analyses of gene expression
alteration elicited by one type of experimental infusion. Duode-
num and the proximal part of the jejunum were recovered 45 min
after the end of the infusion and the mucosa was scraped off with a
spatula (OEA measurement), frozen immediately in liquid
nitrogen and stored at 280uC until used.
Plasma and tissue measurements
Commercially available EIA kits were used to measure the
plasma level of insulin (Crystalchem, Chicago, USA) and
Cholecystokinin, CCK (Phoenix Europe, Karlsruhe, Germany).
Plasma glucose and triglycerides were measured using commercial
kits (BioMe ´rieux, Marcy-l’Etoile, France).
For lipid analysis, lipids were extracted by 2mL of CHCL3/
MeOH (2/1,v/v) at 85uC for 1h. After addition of 2mL NaCl
(2.5% w/v), the extract was vortexed and the above phase
discarded. The chlorofomic phase was evaporated and dried under
a nitrogen stream and the lipids were dissolved in 100 mLo f
CHCL3/MeOH (2/1,v/v). The lipids were separated by TLC
using chloroform/methanol/1-propanol/methyl acetate/0.25%
KCl (10/4/10/10/3.6, by vol.) or pyridine/chloroform/formic
acid (25/15/3.5, by vol.). The N-oleoyl-phosphatidylethanolamine
(NOPE) is identified by comparison of the Rf with the N-
acylphosphatidylethanolamine (NAPE) used as a standard. The
spots corresponding to the NOPE were scraped and subjected to a
transesterification for 1 h at 80uC in the presence of 3 mL 5%
sulfuric methanol containing C17:0 fatty acid as internal standard.
The fatty acids were separated by GC and the lipids were
quantified by comparison of their peak areas with the standard
C17:0 as described by Testet et al [23].
Quantitative RT-PCR (RT-qPCR)
Quantitative RT-PCR (RT-qPCR) was used to study the
expression of different target genes. Total RNA was extracted
from tissue samples using TRIzol (Invitrogen, Cergy-Pontoise,
France) according to the manufacturer’s protocol. All samples
were treated by DNase I (Invitrogen) before the reverse
transcription. First strand cDNAs were prepared using one mg
RNA and the Moloney Murine Leukemia Virus Reverse
Transcriptase, MMLV (Fermentas, St. Re ´my-Les-Chevreuse
France) in the presence of oligo(dT) primers (Fermentas). The
qPCR reactions were performed using the Light Cycler Fast Start
DNA Master SyBR Green I kit (Roche, Meylan, France) in the
presence of specific primer pairs (Table 2). Samples (in duplicate)
were quantified by comparison with a standard curve obtained by
dilutions of purified target cDNA fragment and mRNA level was
expressed as a ratio between values obtained for the target gene
versus values obtained using the housekeeping genes L19
(intestine) and GAPDH (hypothalamus).
Western Blotting
The jejunum was cut in three parts of equal size and mucosa was
scraped off from the first part (proximal jejunum). Ten mgo f
proteins, prepared from jejunal mucosa, were separated by SDS-
PAGE 10% and transferred to a PVDF membrane (Immobilon-P
transfer membrane, Millipore, Saint-Quentin-en-Yvelines, France).
Immunoblotting was performed using goat antibodies directed
against mouse CD36 (1,000-fold dilution, R&D Systems Europe,
Lille, France) or mouse monoclonal antibodies directed against
mouse beta-actin (1,000-fold dilution; Sigma-Aldrich, Saint Quen-
tin Fallavier, France). Goat anti-mouse (BioRad Laboratories,
Marnes-le-Coquette,France)anddonkeyanti-goat IgG (Santa Cruz
Biotechnology, Tebu-bio France, Le Perray en Yvelines) were used
as secondary antibodies for beta-actin and CD36, respectively. Blots
were revealed using the Immobilon Western Blotting Chemilumi-
nescent HRP Substrate (Millipore SAS, Molsheim, France).
Quantitation of the bands was performed using Adobe Photoshop
software.
Statistics
All statistical analyses were performed using one-way ANOVA,
followed by post hoc testing with Fisher’s protected least square
difference test (PLSD), with the aid of Statview 5.0 software package
(SAS Institute Inc. Cary, NC 27513). Results were expressed as
mean 6 SEM and differences were considered significant at
P,0.05.
Results
Binding of intestinal CD36 with the pharmacological
drug SSO reproduces the lipid-mediated inhibition of
food intake in refed mice
To determine the kinetic of duodenal lipid infusion on food
intake, fasted mice bearing a permanent duodenal catheter,
were infused with saline or 20% IL (6 ml/min for 10 min). Food
intake was significantly lower 30 and 60 min after the end of
luminal infusion of IL as compared to saline solution. For
example, food intake dropped from 0.3360.02g (0.96kcal) to
0.2460.01g (0.70 kcal) in control and IL mice 30 min after
infusions, respectively (Fig 2-A). This satietogen effect was
Table 1. Composition of the different diets.
% mass Standard diet HP diet (casein/Soya)
lipids 3.1 5
carbohydrates 60 10
proteins 16.1 54
2.9 kcal/g 2.99 kcal/g
doi:10.1371/journal.pone.0030686.t001
Table 2. Primers used for the qPCR (from Eurogentec,
Seraing, Belgique).
genes sequences: 59-.39
CD36 sense gatgacgtggcaaagaacag
antisense tcctcggggtcctgagttat
L19 sense agattgaccgtcatatgttgtatca
antisense tttcgtgcttccttggtcttaga
POMC sense atgccgagattctgctacagtcg
antisense ttcatctccgttgccaggaaacac
AGRP sense ctcaagaagacaactgcaggac
antisense tgaagaagcggcagtagcac
GAPDH sense ttccagtatgactccactcacg
antisense agactccacgacatactcagca
doi:10.1371/journal.pone.0030686.t002
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infusion (Fig 2-A).
Expression of CD36 encoding gene was measured by RT-qPCR
in intestine serially divided in 6 segments of equal size, according
to previously described procedures [24]. Consistent with previous
published data [10,11], a progressive decrease in CD36 mRNA
levels was found from duodenum to ileum in control mice (Fig 2-
B). In contrast, a 2-fold decrease in CD36 gene expression was
found in duodenum of IL-infused mice as compared to controls
(Fig 2-B). There was no difference between saline and IL infusions
in the other parts of the small intestine suggesting that the amount
of lipids infused in duodenum was too small to reach another part
of the intestine and affect the expression of Cd36 in jejunum and
ileum (Fig 2-B). No significant differences in Agouti related Protein
(AgRP) and Proopiomelanocortin (POMC) gene expression
between saline and IL-infused mice were found in hypothalamus
removed 45 min after the end of infusions (data not shown). Thus,
the decrease in food intake mediated by an acute infusion of
minute quantities of IL in duodenal lumen was not due to any
alteration in the expression of the genes that are directly involved
in the control of food intake at the hypothalamic level.
To further explore the intestinal CD36 implication either as a
AGLC transporter [19] or a putative receptor [13] in the lipid-
mediated control of food intake, pharmacological manipulation of
the ligand binding site of CD36 was performed using an infusion
of the sulfosuccinimidyl-oleate (SSO) into the duodenal lumen
prior to IL or saline treatment in wild-type and CD36-null mice.
SSO is known to be a specific and irreversible ligand for CD36. By
this reason, it is likely that SSO is able to bind to intestinal CD36
receptor as well as inhibit lipid binding. As expected, a decrease of
food intake took place 30 min after infusion of IL in wild-type
mice (Fig 3). Surprisingly, a more drastic effect was found in SSO-
treated wild-type mice in which subsequent infusion of IL did not
induce an additive inhibitory effect on food intake (Fig 3). Thus,
the irreversible binding of SSO to intestinal CD36 was sufficient to
reproduce the satietogen effect of IL infusion. To verify this
interpretation, we performed the same protocol in CD36-null
mice. Basal food intake measured 30 min after saline infusion was
significantly lower in CD36
-/- mice than in WT (Fig 3). When
CD36 gene is lacking, neither SSO alone nor IL infusion alone or
in association with SSO induced any change in food intake (Fig 3).
Therefore, the binding of intestinal CD36 with a pharmacological
ligand is sufficient to induce satiety. It is noteworthy that this effect
is not secondary to lipid-mediated changes in the satiety hormone
CCK since its plasma levels remained similar between the different
groups (data not shown).
Taken together, these data are consistent with a role of CD36 in
satiety as lipid receptor able to detect the presence of dietary lipids
in intestinal lumen rather than lipid transporter as previously
suggested [19].
Chronic high protein diet affects intestinal CD36 gene
expression, lipid-induced OEA synthesis and satiety
Was the short-term hypophagic effect of an acute lipid load
maintained when the mice were adapted chronically to a
satietogen diet? To address this question, we studied the effect of
Figure 2. Food intake and CD36-encoding mRNA level in
segments of the small intestine after intra-duodenal infusions.
(A): Food intakes were measured 30 min, 1hr and 2 hr after the end of
the infusion and were not cumulated. Each type of infusion was
performed several times on the same animal. * P,0.05 relatively to
saline infusion (for each period of time). The dotted line corresponds to
the reference value at each time (mice infused with saline). The number
of experiments (n=16) corresponds to different animals. (B): The
expression of the gene encoding CD36 was measured by RT-qPCR on
RNA samples obtained 45 min after the end of the infusion. Results
were expressed as mean 6 SEM (CD36 versus L19). * P,0.05 differences
between saline and IL infusions for each part of the small intestine.
doi:10.1371/journal.pone.0030686.g002
Figure 3. Food intake after different intra-duodenal infusions
in wild-type and CD36-invalidated mice. Food intakes were
measured 30 min after the end of each type of infusion performed
either on wild-type (CT, n=15) or CD36-invalidated mice (n=9). a:
P,0.05 relatively to Pyrr/saline infusion in CT; b:P ,0.05 relatively to
Pyrr/IL infusion in CT.
doi:10.1371/journal.pone.0030686.g003
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response to an acute lipid infusion. For this purpose, wild-type
mice were subjected for several days to a high-protein diet (HPD).
Indeed, it is well known that a chronic HPD is highly satiating and
the small intestine is able to adapt its gene expression to its dietary
environment [25]. HPD led to a 40% decrease in food intake,
from day 1 to day 5. Afterwards, this satiety effect was stabilized at
around 15-20% below the control levels (standard chow-fed mice)
(Fig 4-A). There were no significant differences in food intake
between mice fed either standard chow or HPD in CD36-null
mice (Figure 4B). This unexpected data suggests that CD36 gene
was required for the satiety effects of HPD. This HP diet up-
regulated the intestinal CD36 gene expression (mRNA and protein
levels) in proximal intestine of wild-type mice fed on HPD
compared to control mice fed on standard laboratory chow (Fig 4-
C & D). This effect was more drastic after 4 days of HPD, when
food intake was especially low (Fig 4-A), than at days 12 and 30
(Fig 4-C). This effect seems to target specifically CD36, since no
induction of the expression of genes encoding other lipid-binding
proteins such as L-FABP was found (data not shown). HPD-
mediated change in the intestinal CD36 gene expression was
associated with a decrease in plasma triglyceride and insulin levels
after 4 days of diet, while the decrease in food intake was especially
pronounced (Fig 4-E and -F).
To explore the impact of this HPD-mediated up-regulation of
CD36 gene expression on regulation of food intake, saline or IL
infusions into duodenum were performed. As expected, HPD-fed
mice had a significant lower food intake levels than control group
(Fig 5-A). In contrast to the standard chow-fed mice, in which IL
infusion led to a decrease in food intake, no significant satietogen
effect of IL was found in mice fed HPD (Figure 5-A). Moreover,
the decrease in the duodenal CD36 mRNA levels found in mice
fed the control chow and subjected to an IL infusion, was not
significantly different in HPD fed animals (Fig 5B).
There was no significant difference in plasma levels of insulin
and glucose 45 min after IL infusion and refeeding, compared to
saline infusion (Table 3). As well, there was no difference in insulin
level between control and HPD-fed mice but a reduction of
glycaemia was observed in HPD-fed mice compared to controls
(Table 3).
The lipid messenger OEA was measured in intestinal mucosa
45 min after the end of saline or IL infusions in mice fed the
standard chow or HPD. Consistent with previously published data
[19], OEA was increased in standard chow-fed mice after IL
infusion relatively to saline (Figure 5-C) which is consistent with
the IL-mediated decrease in food intake. The concentration of
OEA after saline infusions was significantly higher in HPD-fed
mice than in standard chow-fed mice, but no additive effect on
intestinal OEA levels occurred after IL infusion in contrast with
what was found in mice fed the control chow.
Discussion
Acute infusion of minute amount of lipids (0.12 kCal for 10 min)
in duodenum from 5h-fasted mice induced a transient reduction of
food intake during refeeding. Our data show that the binding of
intestinal CD36 with the pharmacogical drug SSO is sufficient to
reproduce this lipid-mediated regulation. Therefore, the ligand
binding of intestinal CD36 appears to be a major step in the onset
of the satiety triggered by the lipid content of the diet. Along with a
decrease in food intake, the lipid infusion induced a decline in
CD36 gene expression only at the site of IL infusion (i.e.
duodenum). Such a reduction of CD36 mRNA levels has
previously been observed after 1hr of intraduodenal infusion of
oleate in rats [11]. This long-lasting infusion induced a diminished
CD36 expression not only in duodenum but also in the jejunum
part of the intestine. Thus, the lipid-induced down-regulation of
the CD36 mRNA extended to the two proximal parts of the small
intestine after a 1hr-infusion was limited to the duodenum after a
shorter infusion. Such differences observed on cd36 gene
regulation could likely be related to the duration of the infusion
and the amount of fat available to bind the protein CD36 localized
at the site of infusion. In line with a potential role as a lipid
receptor, which has been proposed for intestinal CD36 [13,26], we
might therefore draw a parallel between these effects and the well-
known down-regulation phenomenon induced by some agonists
on their specific receptors [27,28] that could reflect an activation
of the protein CD36. Contrary to this rapid decrease in CD36
gene expression after an acute infusion of lipid, chronic feeding
with a high fat diet induced an induction of CD36 mRNA levels
[10,25] suggesting, in this case, an adaptation to the diet to favour
lipid absorption.
A satiating effect of dietary fat has previously been described,
mainly by using rat infused with a higher amount of fat during
longer periods of time [18,29]. Recently, Schwartz et al [19], using
short infusions of a low amount of lipids (0.2 kcal Intralipid during
10 min), have demonstrated a reduction of the consumption of a
liquid diet, as measured 30 min after the end of the infusion in
wild-type mice, but not in cd36-invalidated mice. Our results are in
good agreement with these findings. As the transgenic model
previously used by Schwartz et al [19] is not a tissue-specific
invalidation, we instead preferred to use the sulfosuccinimidyl-
oleate (SSO) to limit the inhibition of the CD36 protein to the
small intestine. This compound was first described as an inhibitor
of LCFA uptake in adipocytes [30]. It specifically binds to the
CD36 protein and has been mostly used for in vitro studies in
several cell models [31,32] where it alters LCFA transport by
CD36 but does not affect the metabolism of these fatty acids [32].
When SSO was infused into the duodenum 5 min prior the saline
or IL perfusions, there was no modification of food intake by IL,
demonstrating the involvement of the intestinal CD36 in the
feeding reduction induced by lipid infusion. However, when SSO
was infused prior the saline infusion, a decrease in food intake
compared to mice infused Pyrr/saline, was already observed that
seems totally dependent on the presence of CD36, as this effect
was completely absent in cd36-knockout mice. Such a CD36-
dependent decrease in food intake induced by SSO alone might
depend on its capacity to elicit cell signalling further to binding
CD36, in addition to its known role as a competitive inhibitor of
fatty acid binding. Such a lipid binding effect has been recently
described by Tran et al [13]. Therefore, the reduction in food
intake after acute fat load and refeeding was clearly in direct
relation with the presence of a functional CD36 in the small
intestine.
What is the contribution of this CD36-mediated satietogen
effect in a long term satiety-inducing diet? Some studies have
demonstrated that the duodenal infusion of lipids in rats inhibits
food intake by decreasing meal frequency, but not the meal size
[33]. As well, when rats where adapted to a high-protein diet, they
reduce the number of meals when compared to rats fed a standard
diet [34]. This type of imbalanced diet has been currently used to
help humans to lose weight [35] and mechanistic studies have
been performed in animal models [36,37]. Unexpectedly, chronic
HP diet, like chronic HF diet [25], induced an increase in CD36
mRNA and protein levels in duodenum and proximal jejunum.
These results suggest that the potential capacity to absorb dietary
LCFA was increased by this HPD, as well as the capacity of the
intestine to signal for a decrease in food intake. Prior to the
Intestinal CD36, Ligand Binding and Satiety
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daily food intake. A reduction in food intake was also observed in
HPD mice after saline infusion and refeeding, as compared to
infused standard-fed mice, but there was no further decrease after
IL infusion. The absence of down-regulation of CD36 mRNA
level by IL, in the HPD group might be related to a defective
activation of CD36 by lipid infusion and could explain the absence
of an additional decrease in food intake.
It has been postulated that OEA acts as a messenger to control
the anorexigenic effect of lipids [19]. When directly administered
to free-feeding rats, OEA inhibits food intake by delaying meal
initiation [38,39]. In food-deprived animals, OEA delays feeding
onset but also reduces meal size [38]. This lipid messenger is
produced by proximal small intestine [40] and is an endogenous
ligand for peroxisome proliferator-activated receptor-a, PPAR-a
[41]. The level of its synthesis is decreased by fasting and increased
after refeeding [39]. Moreover, OEA is capable of increasing
CD36 mRNA expression in intestinal mucosa [42]. Schwartz et al
[19] have previously shown that small-intestine OEA production
by mice increases by 30 min after a refeeding which follows a 6h-
fast, when compared to the level measured just before refeeding.
Herein, we showed that OEA level increased 45 min after IL
(versus saline) perfusion of mice, as previously demonstrated for IL
infused rats [19]. Moreover, when measured 45min after the end
of the saline infusion that corresponds to the beginning of
refeeding, the jejunal OEA level was much higher in HP group
than in control group. We can postulate that this excessive OEA
production in response to fasting and refeeding might partly
explain the sustained decrease in food intake observed in chronic
feeding with HP diet. This higher amount of OEA produced by
proximal jejunum in HPD-fed mice versus controls (standard chow-
fed mice) is in good agreement with the higher expression of CD36
in the proximal small intestine of HPD-fed mice [42]. Moreover,
there was no OEA overproduction in response to IL infusion in the
HPD group. The reason is probably the excessive jejunal OEA
production already induced by refeeding in HPD-fed mice
compared to control mice, which might be sub-maximal, making
it independent of fat infusion. Indeed, Schwartz et al [19] have
demonstrated that OEA is increased after refeeding in standard
chow-fed mice, but results described herein indicate that this
increase was more pronounced in HPD-fed mice. This effect is
CD36-dependent as after cd36 deletion it was lost [19]. Moreover,
the use of CD36 null mice indicated that the hypophagia effect of
the high-protein diet was, at least partly, dependent on the
presence of CD36. Indeed, other mechanisms have been described
to explain the reduction of food intake obtained after HPD
Figure 4. Wild-type and CD36-invalidated mice on Protein-enriched (HP) diet. (A-B): Food intake relative to body weight during 12 days of
standard or HP diets. (A) corresponds to wild-type (WT) mice and (B) to CD36-invalidated mice (C): CD36-encoding mRNA level (relative to L19 gene)
in the duodenum and proximal jejunum of WT mice fed standard or HP diet. (? P,0.05 relative to duodenum control; * P,0.05 relative to jejunum
control; n=5 to 8). (D): Western Blot analyses of proteins prepared from proximal jejunum of WT mice on standard (Control) or HP diet for 4 and 12
days. Each lane corresponded to a different mouse. (E): Plasma triglycerides measured in control and HPD-fed WT mice. a: P,0.05 differences
between control and HPD mice at each period of time; b: P,0.05 relatively to HP 4days. (F): Plasma insulin measured in control and HPD-fed WT mice.
a: P,0.05 differences between control and HPD mice at each period of time; b: P,0.05 relatively to HP 4days.
doi:10.1371/journal.pone.0030686.g004
Figure 5. Comparison between WT mice on standard chow
(control) and HPD after saline or IL infusion. Mice were fed either
standard chow or HP diet 12 days before surgery. Saline and IL infusions
were performed after one-week recovery. (A): Food intakes were
measured 30 min after saline and IL infusions (n=29 for CT and 17 for
HP). (B/C): Duodenal CD36 mRNA level (B) and jejunal OEA
concentration (C) were measured 45 min after the end of saline and
IL infusions. a: P,0.05 relatively to saline infusion in control group.
doi:10.1371/journal.pone.0030686.g005
Table 3. Plasma insulin and glucose levels in control and HP-
fed mice after infusion and refeeding.
perfusion insulin (ng/mL) glucose (mM)
control saline 0.5060.09 10.860.1
IL 0.5860.12 10.560.3
HPD saline 0.5960.10 8.5
a60.4
IL 0.5160.06 8.8
b60.5
a: P,0.05 relatively to saline-infused control; b: P,0.05 relatively to IL-infused
control.
doi:10.1371/journal.pone.0030686.t003
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glucose production and, in particular, it increases the amount of
glucose released by the small intestine that in turn initiates
satiating signals to the brain [36].
We postulate that OEA production may be induced by at least
two different mechanisms. An acute intestinal lipid load generates
OEA synthesis which requires a functional CD36 protein [19]. In
the case of an adaptation to a chronic high-protein diet, wild-type
mice exhibit an exaggerated response to refeeding, leading to
OEA overproduction. In this case, an acute lipid load will not
produce any further increase in OEA production as well as no
additional decrease in food intake.
In conclusion, data presented herein, demonstrate that CD36
present in the small intestine is an active player in the lipid-
mediated induction of satiety. The experiments using SSO in WT
and CD36-null mice, suggest that lipid binding to intestinal CD36
is sufficient to produce a satiety effect. These data suggest that
CD36 might control the OEA production/mobilization via an
activation of cell signalling [13] which in turn might modulate the
activities of NAPE and/or FAAH [19]. Moreover, CD36 could
participate in the satiety effect induced by HPD. The small
intestine has a high capacity to adapt to different types of diet. This
has been demonstrated for lipid-enriched diet, with the acquisition
of an increased capacity to absorb fat in response to the
enrichment in dietary fat. Herein, we show that intestine can also
adapt to a protein-enriched diet partly by CD36-dependent
mechanism and participate to the modulation of food intake by
several mechanisms including an increase in OEA production and
CD36 gene expression. Furthermore, intestine of mice adapted to
HP diet have a diminished capacity to modulate their food intake
in response to dietary lipids present in the meal. Overall, our study
brings new data in favour of the hypotheses advanced by some
authors of a specific role of intestinal CD36 as a lipid receptor.
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